Strides Pharma (STAR)
FAST GROWERFairStock Score: 54/100 — MIXED
Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1,069 |
| Market Cap | ₹7,848.97 Cr |
| P/E Ratio | 14.29 |
| ROCE | 14.68% |
| ROE | 5.22% |
| Dividend Yield | 0.47% |
| Profit Growth | 128.03% |
| Debt/Equity | 0.66 |
| Sales Growth | 3.55% |
| Promoter Holding | 27.86% |
| 52-Week Range | ₹768.65 — ₹1,231.45 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹374.74 |
Strides Pharma trades with a P/E ratio of 14.29, ROCE of 14.68%, ROE of 5.22%, profit growth of 128.03%, debt-to-equity of 0.66. The FairStock Score of 54/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer